First Trust Advisors LP grew its holdings in shares of American Vanguard Corp. (NYSE:AVD) by 18.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,093 shares of the basic materials company’s stock after buying an additional 7,562 shares during the quarter. First Trust Advisors LP owned approximately 0.16% of American Vanguard worth $731,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of AVD. BlackRock Inc. grew its position in shares of American Vanguard by 7.4% during the 3rd quarter. BlackRock Inc. now owns 4,213,602 shares of the basic materials company’s stock worth $75,843,000 after purchasing an additional 291,248 shares in the last quarter. Vanguard Group Inc lifted its holdings in shares of American Vanguard by 3.5% during the 3rd quarter. Vanguard Group Inc now owns 2,737,677 shares of the basic materials company’s stock worth $49,278,000 after acquiring an additional 93,491 shares during the period. Vanguard Group Inc. lifted its holdings in shares of American Vanguard by 3.5% during the 3rd quarter. Vanguard Group Inc. now owns 2,737,677 shares of the basic materials company’s stock worth $49,278,000 after acquiring an additional 93,491 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of American Vanguard by 0.7% during the 3rd quarter. Dimensional Fund Advisors LP now owns 2,524,481 shares of the basic materials company’s stock worth $45,442,000 after acquiring an additional 17,793 shares during the period. Finally, Bank of New York Mellon Corp lifted its holdings in shares of American Vanguard by 2.3% during the 3rd quarter. Bank of New York Mellon Corp now owns 463,778 shares of the basic materials company’s stock worth $8,348,000 after acquiring an additional 10,596 shares during the period. 77.39% of the stock is currently owned by hedge funds and other institutional investors.
Several equities analysts recently commented on AVD shares. ValuEngine downgraded shares of American Vanguard from a “hold” rating to a “sell” rating in a research note on Tuesday, April 9th. Zacks Investment Research cut shares of American Vanguard from a “buy” rating to a “hold” rating in a research report on Thursday, March 14th.
American Vanguard (NYSE:AVD) last posted its quarterly earnings results on Monday, March 11th. The basic materials company reported $0.25 EPS for the quarter, topping analysts’ consensus estimates of $0.23 by $0.02. American Vanguard had a net margin of 5.33% and a return on equity of 7.48%. The business had revenue of $131.00 million during the quarter, compared to analysts’ expectations of $131.60 million. Sell-side analysts anticipate that American Vanguard Corp. will post 0.9 EPS for the current fiscal year.
The company also recently declared a quarterly dividend, which was paid on Wednesday, April 10th. Investors of record on Wednesday, March 27th were given a dividend of $0.02 per share. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.46%. The ex-dividend date of this dividend was Tuesday, March 26th. American Vanguard’s payout ratio is currently 9.88%.
In related news, insider John Rizzi sold 7,470 shares of the firm’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $18.43, for a total transaction of $137,672.10. Following the transaction, the insider now directly owns 43,072 shares of the company’s stock, valued at $793,816.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.20% of the stock is owned by company insiders.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
See Also: Capital gains and your 401(k) or IRA
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.